Variant report
Variant | esv2494215 |
---|---|
Chromosome Location | chr2:116196176-116197917 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:45)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:45 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr2:116196453-116196805 | GM12878 | blood: | n/a | n/a |
2 | BCL11A | chr2:116196322-116196853 | GM12878 | blood: | n/a | n/a |
3 | BCL11A | chr2:116196313-116196863 | GM12878 | blood: | n/a | n/a |
4 | CTCF | chr2:116196381-116196414 | GM19239 | blood: | n/a | n/a |
5 | CTCF | chr2:116196560-116196710 | HMEC | breast: | n/a | n/a |
6 | CTCF | chr2:116196792-116196876 | Medullo | brain: | n/a | n/a |
7 | CTCF | chr2:116196636-116196683 | MCF-7 | breast: | n/a | n/a |
8 | EBF1 | chr2:116196300-116196816 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr2:116196320-116196898 | GM12878 | blood: | n/a | n/a |
10 | EP300 | chr2:116196659-116196901 | GM12878 | blood: | n/a | n/a |
11 | FOSL2 | chr2:116196280-116196854 | HepG2 | liver: | n/a | n/a |
12 | FOSL2 | chr2:116196257-116196821 | HepG2 | liver: | n/a | n/a |
13 | GABPA | chr2:116196296-116196887 | HepG2 | liver: | n/a | n/a |
14 | HEY1 | chr2:116196304-116196623 | K562 | blood: | n/a | n/a |
15 | IRF4 | chr2:116196213-116196806 | GM12878 | blood: | n/a | n/a |
16 | IRF4 | chr2:116196179-116197041 | GM12878 | blood: | n/a | n/a |
17 | JUND | chr2:116196289-116196805 | HepG2 | liver: | n/a | n/a |
18 | JUND | chr2:116196721-116196839 | HepG2 | liver: | n/a | n/a |
19 | MAFK | chr2:116197533-116197670 | HepG2 | liver: | n/a | n/a |
20 | MYC | chr2:116196636-116196682 | MCF-7 | breast: | n/a | n/a |
21 | NR3C1 | chr2:116196279-116196850 | A549 | lung: | n/a | n/a |
22 | PAX5 | chr2:116196225-116196842 | GM12878 | blood: | n/a | n/a |
23 | PAX5 | chr2:116196135-116196961 | GM12878 | blood: | n/a | n/a |
24 | POLR2A | chr2:116196194-116196218 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | POLR2A | chr2:116196295-116196799 | GM12878 | blood: | n/a | n/a |
26 | POU2F2 | chr2:116196176-116196936 | GM12891 | blood: | n/a | n/a |
27 | POU2F2 | chr2:116196269-116196946 | GM12878 | blood: | n/a | n/a |
28 | REST | chr2:116196326-116196752 | HepG2 | liver: | n/a | n/a |
29 | RXRA | chr2:116196379-116196722 | HepG2 | liver: | n/a | n/a |
30 | SIN3AK20 | chr2:116196360-116196774 | HepG2 | liver: | n/a | n/a |
31 | SIN3AK20 | chr2:116196459-116196759 | HepG2 | liver: | n/a | n/a |
32 | SIX5 | chr2:116196292-116196692 | K562 | blood: | n/a | n/a |
33 | SIX5 | chr2:116196273-116196782 | GM12878 | blood: | n/a | n/a |
34 | SP1 | chr2:116196453-116196940 | HepG2 | liver: | n/a | n/a |
35 | SP1 | chr2:116196508-116196844 | GM12878 | blood: | n/a | n/a |
36 | SP1 | chr2:116196231-116196856 | GM12878 | blood: | n/a | n/a |
37 | SPI1 | chr2:116196297-116196891 | GM12878 | blood: | n/a | n/a |
38 | TAF1 | chr2:116196308-116196904 | HepG2 | liver: | n/a | n/a |
39 | TCF12 | chr2:116196472-116196746 | GM12878 | blood: | n/a | n/a |
40 | USF1 | chr2:116196454-116196950 | A549 | lung: | n/a | n/a |
41 | USF1 | chr2:116196319-116196725 | HepG2 | liver: | n/a | n/a |
42 | ZBTB33 | chr2:116196451-116196924 | HepG2 | liver: | n/a | n/a |
43 | ZBTB33 | chr2:116196215-116196846 | GM12878 | blood: | n/a | n/a |
44 | ZBTB33 | chr2:116196519-116196932 | K562 | blood: | n/a | n/a |
45 | ZBTB33 | chr2:116196375-116196963 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
DPP10 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs78259760 | chr2:116196183-116196184 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs556545997 | chr2:116196250-116196251 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs117378642 | chr2:116196273-116196274 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs539147797 | chr2:116196275-116196276 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs187452089 | chr2:116196280-116196281 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs111330354 | chr2:116196285-116196286 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs111578587 | chr2:116196289-116196290 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs111876541 | chr2:116196296-116196297 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs112108580 | chr2:116196314-116196315 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs112422236 | chr2:116196321-116196322 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs75799482 | chr2:116196325-116196326 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs112658410 | chr2:116196332-116196333 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs13397992 | chr2:116196357-116196358 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs111948925 | chr2:116196361-116196362 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs111447987 | chr2:116196368-116196369 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs77027491 | chr2:116196374-116196375 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs111672481 | chr2:116196386-116196387 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs574706623 | chr2:116196388-116196389 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs61081814 | chr2:116196393-116196394 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs59075983 | chr2:116196397-116196398 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs76892169 | chr2:116196404-116196405 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs78546591 | chr2:116196410-116196411 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs543349693 | chr2:116196422-116196423 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs60543060 | chr2:116196429-116196430 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs111287241 | chr2:116196433-116196434 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs376396656 | chr2:116196434-116196435 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs34971157 | chr2:116196440-116196441 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs34940083 | chr2:116196446-116196447 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs563337131 | chr2:116196458-116196459 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs57442248 | chr2:116196465-116196466 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs34609071 | chr2:116196476-116196477 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs112431211 | chr2:116196501-116196502 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs34464355 | chr2:116196512-116196513 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs112617944 | chr2:116196518-116196519 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs113129855 | chr2:116196530-116196531 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs112425295 | chr2:116196537-116196538 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs28488534 | chr2:116196548-116196549 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs60833883 | chr2:116196554-116196555 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs572843429 | chr2:116196566-116196567 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs368812649 | chr2:116196584-116196585 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs556070883 | chr2:116196590-116196591 | Weak transcription ZNF genes & repeats | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs372968572 | chr2:116196602-116196603 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs34110208 | chr2:116196620-116196621 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs560156146 | chr2:116196626-116196627 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs375112618 | chr2:116196638-116196639 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs843413 | chr2:116196656-116196657 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs551858224 | chr2:116196657-116196658 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs55960701 | chr2:116196674-116196675 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs77860391 | chr2:116196692-116196693 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs77577194 | chr2:116196710-116196711 | Weak transcription Genic enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Mental retardation | 17621639 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:116189400-116198800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:116194400-116198800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr2:116195400-116196600 | Weak transcription | Pancreas | Pancrea |
4 | chr2:116196200-116196400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr2:116196400-116196600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr2:116196600-116196800 | Genic enhancers | Pancreas | Pancrea |
7 | chr2:116196600-116203400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr2:116196800-116203400 | Weak transcription | Pancreas | Pancrea |
9 | chr2:116197400-116197800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr2:116197400-116197800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
11 | chr2:116197400-116198000 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
12 | chr2:116197600-116197800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr2:116197600-116198600 | Active TSS | HUES6 Cell Line | embryonic stem cell |
14 | chr2:116197600-116198800 | Active TSS | iPS-20b Cell Line | embryonic stem cell |
15 | chr2:116197800-116198000 | Flanking Active TSS | HUES64 Cell Line | embryonic stem cell |
16 | chr2:116197800-116198000 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
17 | chr2:116197800-116198400 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
18 | chr2:116197800-116198800 | Active TSS | HUES48 Cell Line | embryonic stem cell |
19 | chr2:116197800-116201200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |